Difference between revisions of "Template:Chemotherapeutic agents"
Jump to navigation
Jump to search
| Line 192: | Line 192: | ||
* ''[[cyclin-dependent kinase|CDK]] [[Protein kinase inhibitor|inhibitor]]s'' ([[Alvocidib]]<sup>†</sup> | * ''[[cyclin-dependent kinase|CDK]] [[Protein kinase inhibitor|inhibitor]]s'' ([[Alvocidib]]<sup>†</sup> | ||
* [[Seliciclib]]<sup>†</sup>) | * [[Seliciclib]]<sup>†</sup>) | ||
| + | * [[Palbociclib]]<sup>†</sup> | ||
* ''[[Proteasome inhibitor|PrI]]'' ([[Bortezomib]] | * ''[[Proteasome inhibitor|PrI]]'' ([[Bortezomib]] | ||
* [[Carfilzomib]]) | * [[Carfilzomib]]) | ||
Revision as of 07:20, 15 January 2015
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Chemotherapeutic agents|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Chemotherapeutic agents|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Chemotherapeutic agents|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.